Related Experiment Video
Updated: Jul 4, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Endogenous adipose-derived factors diminish coronary endothelial function via inhibition of nitric oxide synthase
Gregory A Payne1, Léna Borbouse, Ian N Bratz
1Department of Cellular and Integrative Physiology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Abstract:
Adipocytokines may be the molecular link between obesity and vascular disease. However, the effects of these factors on coronary vascular function have not been discerned. Accordingly, the goal of this investigation was to delineate the mechanisms by which endogenous adipose-derived factors affect coronary vascular endothelial function. Both isolated canine coronary arteries and coronary blood flow in anesthetized dogs were studied with and without exposure to adipose tissue. Infusion of adipose-conditioned buffer directly into the coronary circulation did not change baseline hemodynamics; however, endothelial-dependent vasodilation to bradykinin was impaired both in vitro and in vivo. Coronary vasodilation to sodium nitroprusside was unaltered by adipose tissue. Oxygen radical formation did not cause the impairment because quantified dihydroethidium staining was decreased by adipose tissue and neither a superoxide dismutase mimetic nor catalase improved endothelial function. Inhibition of nitric oxide (NO) synthase with L-NAME diminished bradykinin-mediated relaxations and eliminated the subsequent vascular effects of adipose tissue. In vitro measurement of NO demonstrated that adipose tissue exposure quickly lowered baseline NO and abolished bradykinin-induced NO production. The results indicate that adipose tissue releases factor(s) that selectively impair endothelial-dependent dilation via inhibition of NO synthase-mediated NO production.
Insights
Adipose tissue releases factors that impair blood vessel function by inhibiting nitric oxide (NO) production. This finding links obesity to vascular disease by affecting endothelial-dependent vasodilation.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Obesity Research
Background:
- Obesity is linked to vascular disease, with adipocytokines potentially mediating this connection.
- The precise impact of adipose-derived factors on coronary vascular function remains unclear.
Purpose of the Study:
- To investigate the mechanisms by which endogenous adipose-derived factors influence coronary vascular endothelial function.
- To determine if adipose tissue affects endothelial-dependent and independent vasodilation.
Main Methods:
- Studied isolated canine coronary arteries and coronary blood flow in anesthetized dogs.
- Exposed vessels and blood flow to adipose tissue or adipose-conditioned buffer.
- Utilized bradykinin for endothelial-dependent vasodilation and sodium nitroprusside for endothelial-independent vasodilation.
- Assessed nitric oxide (NO) production and oxidative stress markers.
Main Results:
- Adipose tissue impaired endothelial-dependent vasodilation to bradykinin but not endothelial-independent vasodilation to sodium nitroprusside.
- Adipose tissue reduced baseline and bradykinin-stimulated nitric oxide (NO) production.
- Inhibition of NO synthase with L-NAME mimicked the effect of adipose tissue, and blocking NO synthase abolished adipose tissue's impact.
- Oxidative stress was not the cause of impaired vasodilation.
Conclusions:
- Adipose tissue releases factors that selectively inhibit endothelial-dependent vasodilation.
- These factors act by suppressing nitric oxide synthase-mediated NO production.
- This mechanism provides insight into how obesity contributes to vascular dysfunction.
Related Concept Videos
Nitric Oxide Signaling Pathway
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
